Alessandra Pompa

577 total citations
23 papers, 244 citations indexed

About

Alessandra Pompa is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Alessandra Pompa has authored 23 papers receiving a total of 244 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hematology, 9 papers in Genetics and 7 papers in Molecular Biology. Recurrent topics in Alessandra Pompa's work include Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Alessandra Pompa is often cited by papers focused on Multiple Myeloma Research and Treatments (19 papers), Protein Degradation and Inhibitors (6 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers). Alessandra Pompa collaborates with scholars based in Italy, United States and Australia. Alessandra Pompa's co-authors include Alessandro Corso, Virginia Valeria Ferretti, Silvia Mangiacavalli, Federica Cocito, Mario Cazzola, Luca Baldini, Catherine Klersy, Marzia Varettoni, Giuseppe Milone and Ivan Borrello and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Alessandra Pompa

22 papers receiving 242 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alessandra Pompa Italy 10 172 101 91 50 16 23 244
Federica Cocito Italy 10 159 0.9× 118 1.2× 83 0.9× 37 0.7× 19 1.2× 22 231
Julia Foster United States 9 155 0.9× 53 0.5× 152 1.7× 55 1.1× 10 0.6× 17 360
Sanjeevan Sharma India 11 216 1.3× 96 1.0× 59 0.6× 57 1.1× 21 1.3× 53 306
P. Talley United Kingdom 5 119 0.7× 60 0.6× 85 0.9× 73 1.5× 97 6.1× 6 296
B‐M Frost Sweden 8 78 0.5× 77 0.8× 66 0.7× 28 0.6× 14 0.9× 13 256
Stefanie Jilg Germany 6 140 0.8× 99 1.0× 30 0.3× 53 1.1× 9 0.6× 15 219
Holger Hauch Germany 8 42 0.2× 75 0.7× 37 0.4× 75 1.5× 53 3.3× 29 258
Richy Agajanian United States 10 150 0.9× 130 1.3× 145 1.6× 29 0.6× 30 1.9× 32 318
Olga Mulas Italy 7 105 0.6× 30 0.3× 48 0.5× 77 1.5× 9 0.6× 35 190
Bhuvan Kishore United Kingdom 8 158 0.9× 106 1.0× 83 0.9× 23 0.5× 18 1.1× 39 240

Countries citing papers authored by Alessandra Pompa

Since Specialization
Citations

This map shows the geographic impact of Alessandra Pompa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandra Pompa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandra Pompa more than expected).

Fields of papers citing papers by Alessandra Pompa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alessandra Pompa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandra Pompa. The network helps show where Alessandra Pompa may publish in the future.

Co-authorship network of co-authors of Alessandra Pompa

This figure shows the co-authorship network connecting the top 25 collaborators of Alessandra Pompa. A scholar is included among the top collaborators of Alessandra Pompa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandra Pompa. Alessandra Pompa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dimopoulos, Meletios Α., Fredrik Schjesvold, Vadim Doronin, et al.. (2022). Oral ixazomib-dexamethasone vs oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma: a randomized Phase 2 trial. Blood Cancer Journal. 12(1). 9–9. 15 indexed citations
3.
Pompa, Alessandra, Diana Giannarelli, Laura París, et al.. (2021). Safety of outpatient stem cell mobilization with low‐ or intermediate‐dose cyclophosphamide in newly diagnosed multiple myeloma patients. European Journal Of Haematology. 107(5). 566–572. 2 indexed citations
4.
Dimopoulos, Meletios Α., Fredrik Schjesvold, Vadim Doronin, et al.. (2021). Oral ixazomib-dexamethasone versus oral pomalidomide-dexamethasone for lenalidomide-refractory, proteasome inhibitor-exposed multiple myeloma (MM) patients: A global, multicenter, randomized, open-label, phase 2 trial.. Journal of Clinical Oncology. 39(15_suppl). 8020–8020. 1 indexed citations
5.
Manzoni, Martina, Valentina Marchica, Paola Storti, et al.. (2020). Application of Next-Generation Sequencing for the Genomic Characterization of Patients with Smoldering Myeloma. Cancers. 12(5). 1332–1332. 6 indexed citations
6.
Cocito, Federica, Silvia Mangiacavalli, Virginia Valeria Ferretti, et al.. (2019). Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practice. Leukemia & lymphoma. 60(12). 2968–2974. 4 indexed citations
7.
Todoerti, Katia, Giovanni Calice, Stefania Trino, et al.. (2018). Global methylation patterns in primary plasma cell leukemia. Leukemia Research. 73. 95–102. 12 indexed citations
8.
Loglio, Alessandro, Mauro Viganò, G. Grossi, et al.. (2018). Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma. Digestive and Liver Disease. 51(3). 419–424. 7 indexed citations
9.
10.
Mangiacavalli, Silvia, Alessandra Pompa, Virginia Valeria Ferretti, et al.. (2016). The possible role of burden of therapy on the risk of myeloma extramedullary spread. Annals of Hematology. 96(1). 73–80. 37 indexed citations
11.
Neri, Antonino, Katia Todoerti, Marta Lionetti, et al.. (2016). Primary plasma cell leukemia 2.0: advances in biology and clinical management. Expert Review of Hematology. 9(11). 1063–1073. 14 indexed citations
12.
Pompa, Alessandra, Francesca Guidotti, Maria Goldaniga, et al.. (2016). Outpatient Stem Cell Mobilization with Intermediate-Dose Cyclophosphamide Is a Safe and Effective Procedure. Blood. 128(22). 5734–5734.
13.
Pompa, Alessandra, Francesca Guidotti, Maria Goldaniga, et al.. (2016). Four Cases of Lenalidomide-Associated Immune Thrombocytopenia. Blood. 128(22). 4927–4927. 4 indexed citations
14.
Romano, Alessandra, Nunziatina Laura Parrinello, Luigi Marchionni, et al.. (2015). Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents. Annals of Hematology. 94(11). 1875–1883. 42 indexed citations
15.
Corso, Alessandro, Silvia Mangiacavalli, Federica Cocito, et al.. (2014). Correction: Long Term Evaluation of the Impact of Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: A Cost-Effectiveness Analysis. PLoS ONE. 9(1). 1 indexed citations
16.
Corso, Alessandro, Silvia Mangiacavalli, Federica Cocito, et al.. (2013). Long Term Evaluation of the Impact of Autologous Peripheral Blood Stem Cell Transplantation in Multiple Myeloma: A Cost-Effectiveness Analysis. PLoS ONE. 8(9). e75047–e75047. 11 indexed citations
17.
Mangiacavalli, Silvia, Federica Cocito, Cristiana Pascutto, et al.. (2013). Monoclonal gammopathy of undetermined significance: a new proposal of workup. European Journal Of Haematology. 91(4). 356–360. 22 indexed citations
18.
Nicolucci, Antonio, et al.. (2012). Survey of current practice for monitoring and management of platelet refractoriness in Italy. Transfusion and Apheresis Science. 47(3). 271–276. 6 indexed citations
19.
Mangiacavalli, Silvia, Federica Cocito, Cristiana Pascutto, et al.. (2012). Serum C-Terminal Telopeptide Maintains Its Correlation with Bone Disease in Myeloma Patients Even Under Treatment with Bisphosphonates. Blood. 120(21). 4003–4003. 1 indexed citations
20.
Zoli, A., Alessandra Pompa, A. Barini, et al.. (1999). Basal and After‐stimuli Test for Prolactinemia in Systemic Lupus Erythematosus. Annals of the New York Academy of Sciences. 876(1). 155–158. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Federica Cocito Breakdown of academic impact, for papers by Julia Foster Breakdown of academic impact, for papers by Sanjeevan Sharma Breakdown of academic impact, for papers by P. Talley Breakdown of academic impact, for papers by B‐M Frost Breakdown of academic impact, for papers by Stefanie Jilg Breakdown of academic impact, for papers by Holger Hauch Breakdown of academic impact, for papers by Richy Agajanian Breakdown of academic impact, for papers by Olga Mulas Breakdown of academic impact, for papers by Bhuvan Kishore
Rankless by CCL
2026